|
Volumn 24, Issue 1, 2001, Pages 19-37
|
Evaluation of the immunomodulatory effects of the macrolide antibiotic, clarithromycin, in female B6C3F1 mice: A 28-day oral gavage study
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CLARITHROMYCIN;
IMMUNOGLOBULIN M;
MACROLIDE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANTIBODY PRODUCING CELL;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CELLULAR IMMUNITY;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
DOSE RESPONSE;
EVALUATION;
FEMALE;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMORAL IMMUNITY;
IMMUNE RESPONSE;
IMMUNOGLOBULIN BLOOD LEVEL;
IMMUNOMODULATION;
MACROPHAGE;
MOUSE;
NATURAL KILLER CELL;
NONHUMAN;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
ANTI-BACTERIAL AGENTS;
ANTIBODY FORMATION;
ANTIBODY-PRODUCING CELLS;
BLOOD CELL COUNT;
BODY WEIGHT;
CLARITHROMYCIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
IMMUNOGLOBULIN M;
INTUBATION, GASTROINTESTINAL;
KILLER CELLS, NATURAL;
LYMPHOCYTE ACTIVATION;
MACROPHAGES;
MICE;
MICE, INBRED STRAINS;
ORGAN SIZE;
SPLEEN;
T-LYMPHOCYTES, CYTOTOXIC;
TOXICITY TESTS;
ANIMALIA;
BACTERIA (MICROORGANISMS);
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0035066019
PISSN: 01480545
EISSN: None
Source Type: Journal
DOI: 10.1081/DCT-100103083 Document Type: Article |
Times cited : (7)
|
References (23)
|